SCHEMBL28655531

SCHEMBL28655531

N#Cc1c(Cl)nc2c(Oc3c(O)cccc3F)cccc2c1Cl

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28655555 0.86 AR (0.42) KDM4E
SCHEMBL30774158 0.79 ALDH1A1 (0.37) KDM4E
SCHEMBL24373483 0.79 ALDH1A1 (0.37) KDM4E
SCHEMBL28669735 0.75 CXCR2 (0.37) —
SCHEMBL29479071 0.75 KDM4E (0.51) KDM4E
SCHEMBL24373525 0.75 KDM4E (0.51) KDM4E
SCHEMBL28673314 0.70 ALDH1A1 (0.34) KDM4E
SCHEMBL30950256 0.70 ALDH1A1 (0.34) KDM4E
SCHEMBL24373521 0.68 KDM4E (0.43) KDM4E
SCHEMBL25301152 0.68 PSMB8 (0.37) KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113637005-B KRAS inhibitors for cancer treatment 泰励生物科技(上海)有限公司 2024-05-24 — — CN disclosed
CN-113637005-A KRAS inhibitors for cancer treatment 泰励生物科技(上海)有限公司 2021-11-12 — — CN disclosed
Send feedback